La posologie varie, mais commence souvent à 0,5 mg à 1 mg par jour, ajustée selon les besoins.
PosologieMédicaments antidiabétiquesDiabète
#4
Le Méglutol nécessite-t-il un suivi médical ?
Oui, un suivi régulier est essentiel pour ajuster le traitement et surveiller les effets.
Suivi médicalMédicaments antidiabétiquesDiabète
#5
Quels sont les objectifs du traitement avec Méglutol ?
L'objectif est de maintenir une glycémie normale et de prévenir les complications du diabète.
GlycémieComplications du diabèteTraitement
Complications
5
#1
Quelles sont les complications du diabète non contrôlé ?
Les complications incluent des maladies cardiovasculaires, des neuropathies et des problèmes rénaux.
ComplicationsDiabèteMaladies cardiovasculaires
#2
Le Méglutol réduit-il les risques de complications ?
Oui, un bon contrôle glycémique avec Méglutol peut réduire le risque de complications.
Contrôle glycémiqueComplicationsDiabète
#3
Comment prévenir les complications du diabète ?
Un suivi médical régulier, une bonne hygiène de vie et un contrôle glycémique strict sont essentiels.
PréventionComplicationsSuivi médical
#4
Les complications peuvent-elles être réversibles ?
Certaines complications peuvent être réversibles avec un traitement approprié et un bon contrôle.
ComplicationsTraitementDiabète
#5
Quels examens sont nécessaires pour détecter les complications ?
Des examens réguliers des yeux, des reins et des pieds sont recommandés pour détecter les complications.
Examens médicauxComplicationsDiabète
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque du diabète ?
Les facteurs incluent l'obésité, l'inactivité physique, l'âge et des antécédents familiaux.
Facteurs de risqueDiabèteObésité
#2
Le stress est-il un facteur de risque ?
Oui, le stress chronique peut contribuer à l'augmentation de la glycémie et au diabète.
StressDiabèteGlycémie
#3
L'alimentation influence-t-elle le risque de diabète ?
Oui, une alimentation riche en sucres et en graisses augmente le risque de diabète de type 2.
AlimentationDiabète de type 2Facteurs de risque
#4
L'âge est-il un facteur de risque pour le diabète ?
Oui, le risque de diabète augmente avec l'âge, surtout après 45 ans.
ÂgeDiabèteFacteurs de risque
#5
Les antécédents familiaux jouent-ils un rôle ?
Oui, avoir des membres de la famille atteints de diabète augmente le risque personnel.
Antécédents familiauxDiabèteFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Méglutol : Questions médicales les plus fréquentes",
"headline": "Méglutol : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Méglutol : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-12",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Méglutol"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Glutarates",
"url": "https://questionsmedicales.fr/mesh/D005977",
"about": {
"@type": "MedicalCondition",
"name": "Glutarates",
"code": {
"@type": "MedicalCode",
"code": "D005977",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.241.081.337.351"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Méglutol",
"alternateName": "Meglutol",
"code": {
"@type": "MedicalCode",
"code": "D015093",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Marvin N Iman",
"url": "https://questionsmedicales.fr/author/Marvin%20N%20Iman",
"affiliation": {
"@type": "Organization",
"name": "Department of Biotechnology, Graduate School of Engineering, Osaka University, Japan."
}
},
{
"@type": "Person",
"name": "Danielle E Haslam",
"url": "https://questionsmedicales.fr/author/Danielle%20E%20Haslam",
"affiliation": {
"@type": "Organization",
"name": "Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA."
}
},
{
"@type": "Person",
"name": "Liming Liang",
"url": "https://questionsmedicales.fr/author/Liming%20Liang",
"affiliation": {
"@type": "Organization",
"name": "Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA."
}
},
{
"@type": "Person",
"name": "Kai Guo",
"url": "https://questionsmedicales.fr/author/Kai%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Center for Clinical Research and Health Promotion, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, Puerto Rico, USA."
}
},
{
"@type": "Person",
"name": "Kaumudi Joshipura",
"url": "https://questionsmedicales.fr/author/Kaumudi%20Joshipura",
"affiliation": {
"@type": "Organization",
"name": "Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Center for Clinical Research and Health Promotion, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, Puerto Rico, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A case-control study of infections caused by",
"datePublished": "2022-07-28",
"url": "https://questionsmedicales.fr/article/35967868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcimb.2022.867347"
}
},
{
"@type": "ScholarlyArticle",
"name": "Errors in Surgery: A Case Control Study.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35946794",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/SLA.0000000000005664"
}
},
{
"@type": "ScholarlyArticle",
"name": "Iron status in women with infertility and controls: a case-control study.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37361544",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1173100"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleeve Gastrectomy in Septuagenarians: a Case-Control Study.",
"datePublished": "2022-07-05",
"url": "https://questionsmedicales.fr/article/35788952",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11695-022-06193-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diverticulitis Familiality: A Statewide Case-Control Study.",
"datePublished": "2023-07-05",
"url": "https://questionsmedicales.fr/article/37403933",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/XCS.0000000000000799"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides carboxyliques",
"item": "https://questionsmedicales.fr/mesh/D002264"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides acycliques",
"item": "https://questionsmedicales.fr/mesh/D000144"
},
{
"@type": "ListItem",
"position": 5,
"name": "Diacides carboxyliques",
"item": "https://questionsmedicales.fr/mesh/D003998"
},
{
"@type": "ListItem",
"position": 6,
"name": "Glutarates",
"item": "https://questionsmedicales.fr/mesh/D005977"
},
{
"@type": "ListItem",
"position": 7,
"name": "Méglutol",
"item": "https://questionsmedicales.fr/mesh/D015093"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Méglutol - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Méglutol",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Méglutol",
"description": "Comment diagnostiquer un besoin de Méglutol ?\nQuels tests sont utilisés pour le diabète ?\nQuand envisager le Méglutol ?\nQuels signes indiquent un diabète avancé ?\nLe Méglutol est-il prescrit pour tous les diabétiques ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Case-Control+Studies#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Méglutol",
"description": "Quels symptômes le Méglutol aide-t-il à réduire ?\nLe Méglutol provoque-t-il des effets secondaires ?\nComment reconnaître une hypoglycémie ?\nLe Méglutol affecte-t-il le poids ?\nQuels sont les signes d'une réaction allergique ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Case-Control+Studies#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Méglutol",
"description": "Comment prévenir le diabète de type 2 ?\nLe Méglutol peut-il être utilisé préventivement ?\nQuels modes de vie favorisent la santé métabolique ?\nLes contrôles réguliers de la glycémie sont-ils importants ?\nComment le stress influence-t-il le diabète ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Case-Control+Studies#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Méglutol",
"description": "Comment le Méglutol est-il administré ?\nPeut-on combiner le Méglutol avec d'autres médicaments ?\nQuelle est la posologie habituelle du Méglutol ?\nLe Méglutol nécessite-t-il un suivi médical ?\nQuels sont les objectifs du traitement avec Méglutol ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Case-Control+Studies#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Méglutol",
"description": "Quelles sont les complications du diabète non contrôlé ?\nLe Méglutol réduit-il les risques de complications ?\nComment prévenir les complications du diabète ?\nLes complications peuvent-elles être réversibles ?\nQuels examens sont nécessaires pour détecter les complications ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Case-Control+Studies#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Méglutol",
"description": "Quels sont les principaux facteurs de risque du diabète ?\nLe stress est-il un facteur de risque ?\nL'alimentation influence-t-elle le risque de diabète ?\nL'âge est-il un facteur de risque pour le diabète ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Case-Control+Studies#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un besoin de Méglutol ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de diabète de type 2 est établi par des tests de glycémie et d'insuline."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diabète ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la glycémie à jeun, l'HbA1c et le test de tolérance au glucose."
}
},
{
"@type": "Question",
"name": "Quand envisager le Méglutol ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est envisagé lorsque les changements de mode de vie ne suffisent pas à contrôler la glycémie."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un diabète avancé ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une soif excessive, des mictions fréquentes et une fatigue persistante."
}
},
{
"@type": "Question",
"name": "Le Méglutol est-il prescrit pour tous les diabétiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il est principalement prescrit pour les patients avec un diabète de type 2 non contrôlé."
}
},
{
"@type": "Question",
"name": "Quels symptômes le Méglutol aide-t-il à réduire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il aide à réduire les symptômes liés à l'hyperglycémie, comme la soif et la fatigue."
}
},
{
"@type": "Question",
"name": "Le Méglutol provoque-t-il des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires peuvent inclure des nausées, des diarrhées et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hypoglycémie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des sueurs, des tremblements, de la confusion et une faim intense."
}
},
{
"@type": "Question",
"name": "Le Méglutol affecte-t-il le poids ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut entraîner une légère perte de poids chez certains patients, mais pas chez tous."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une réaction allergique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des éruptions cutanées, des démangeaisons et un gonflement du visage."
}
},
{
"@type": "Question",
"name": "Comment prévenir le diabète de type 2 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice régulier et le maintien d'un poids santé sont essentiels."
}
},
{
"@type": "Question",
"name": "Le Méglutol peut-il être utilisé préventivement ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il est utilisé pour traiter le diabète déjà établi, pas pour la prévention."
}
},
{
"@type": "Question",
"name": "Quels modes de vie favorisent la santé métabolique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une activité physique régulière, une alimentation riche en fibres et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Les contrôles réguliers de la glycémie sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à détecter les anomalies précocement et à ajuster le traitement si nécessaire."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il le diabète ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut augmenter la glycémie, rendant le contrôle du diabète plus difficile."
}
},
{
"@type": "Question",
"name": "Comment le Méglutol est-il administré ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est généralement pris par voie orale, souvent avant les repas pour maximiser son efficacité."
}
},
{
"@type": "Question",
"name": "Peut-on combiner le Méglutol avec d'autres médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être combiné avec d'autres antidiabétiques pour un meilleur contrôle glycémique."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie habituelle du Méglutol ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie, mais commence souvent à 0,5 mg à 1 mg par jour, ajustée selon les besoins."
}
},
{
"@type": "Question",
"name": "Le Méglutol nécessite-t-il un suivi médical ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour ajuster le traitement et surveiller les effets."
}
},
{
"@type": "Question",
"name": "Quels sont les objectifs du traitement avec Méglutol ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'objectif est de maintenir une glycémie normale et de prévenir les complications du diabète."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du diabète non contrôlé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies cardiovasculaires, des neuropathies et des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Le Méglutol réduit-il les risques de complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon contrôle glycémique avec Méglutol peut réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications du diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier, une bonne hygiène de vie et un contrôle glycémique strict sont essentiels."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et un bon contrôle."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour détecter les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers des yeux, des reins et des pieds sont recommandés pour détecter les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du diabète ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, l'inactivité physique, l'âge et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à l'augmentation de la glycémie et au diabète."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de diabète ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en sucres et en graisses augmente le risque de diabète de type 2."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour le diabète ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de diabète augmente avec l'âge, surtout après 45 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des membres de la famille atteints de diabète augmente le risque personnel."
}
}
]
}
]
}
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Center for Clinical Research and Health Promotion, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, Puerto Rico, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Center for Clinical Research and Health Promotion, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, Puerto Rico, USA.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Biotechnology, Graduate School of Engineering, Osaka University, Japan; Industrial Biotechnology Initiative Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Japan; Osaka University-Shimadzu Omics Innovation Research Laboratories, Osaka University, Japan.
Department of Biotechnology, Graduate School of Engineering, Osaka University, Japan; Osaka University-Shimadzu Omics Innovation Research Laboratories, Osaka University, Japan. Electronic address: sastia_putri@bio.eng.osaka-u.ac.jp.
Infections caused by antimicrobial-resistant bacteria are a significant cause of death worldwide, and carbapenemase-producing bacteria are the principal agents. New Delhi metallo-beta-lactamase-1 prod...
A retrospective case-control study with patients hospitalized from January 2012 to February 2018 at the Hospital Civil de Guadalajara "Fray Antonio Alcalde" was designed. During this period, 139 patie...
One hundred and thirty-nine case patients with a KP-NDM-1 isolate and 486 control patients were analyzed. In the case group, acute renal failure was a significant comorbidity, hospitalization days wer...
In this study, the previous use of antibiotics, the use of a urinary catheter, the use of a central venous catheter, the use of mechanical ventilation, and ICU stay were shown to be predictors of infe...
While errors can harm patients they remain poorly studied. This study characterized errors in the care of surgical patients and examined the association of errors with morbidity and mortality....
Errors have been reported to cause <10% or >60% of adverse events. Such discordant results underscore the need for further exploration of the relationship between error and adverse events....
Patients with operations performed at a single institution and abstracted into the American College of Surgeons National Surgical Quality Improvement Program from January 1, 2018, to December 31, 2018...
Of 1899 patients, 170 were defined as cases who experienced a morbidity or mortality. The majority of cases (n=93; 55%) had at least 1 error; of the 329 matched control patients, 112 had at least 1 er...
Errors in surgical care were associated with postoperative morbidity. Reducing errors requires measurement of errors....
Iron deficiency is a common problem in subfertile women. The influence of iron status on unexplained infertility is unknown....
In a case-control study, 36 women with unexplained infertility and 36 healthy non-infertile controls were included. Parameters of iron status including serum ferritin and a serum ferritin <30 µg/dL se...
Women with unexplained infertility demonstrated a lower transferrin saturation (median 17.3%, IQR 12.7-25.2 versus 23.9%, IQR 15.4-31.6;...
Ferritin levels <30µg/L were associated with unexplained infertility and might be screened in the future. Further studies with a focus on iron deficiency and iron treatment on women with unexplained i...
There are few studies published referring to bariatric surgery in patients older than 70 years. The aim of this study is to evaluate whether there are benefits to performing sleeve gastrectomy (SG) in...
Data were retrospectively collected from a Private Clinic's electronic medical records of patients undergoing SG between June 2017 and September 2020. Inclusion criteria were patients older than 70 ye...
Fifty patients were included in the study. Both groups were similar regarding gender, weight, BMI, and presence of DM. The 30-day morbidity and mortality were similar between the groups. The patients ...
The sleeve gastrectomy surgery performed in patients over 70 years of age is safe. The early results suggest similar benefits regarding weight loss and improvement of comorbidities to those having SG ...
The etiology of diverticulitis is multifactorial and poorly understood. We estimated the familiality of diverticulitis using the Utah Population Database, a statewide database linking medical records ...
We identified patients with diverticulitis diagnosed between 1998 and 2018 and age- and sex-matched controls in the Utah Population Database. Risk of diverticulitis in family members of patients and c...
The study population included 9,563 diverticulitis patients (with 229,647 relatives) and 10,588 controls (with 265,693 relatives). Relatives of patients were more likely to develop diverticulitis (inc...
Our results indicate that the first-, second-, and third-degree relatives of diverticulitis patients are at elevated risk of developing diverticulitis. This information may aid surgeons in counseling ...
This study aimed to investigate the clinical and laboratory as well as radiological features of spondyloarthritis (SpA) patients with thrombocytosis and to explore risk factor for thrombocytosis in Sp...
A total of 145 patients with SpA were included in this study, and non-thrombocytosis was identified in 76 patients while thrombocytosis was found in 69 patients, 38 out of the 69 patients received ant...
The proportion of hip involvement (60.86% vs 36.84%, p = 0.004), bath ankylosing spondylitis disease activity index score (4.24 ± 0.55 vs 3.69 ± 0.67, p < 0.001), erythrocyte sedimentation rate (62.22...
SpA patients with thrombocytosis have a higher proportion of hip involvement and disease activity compared to non-thrombocytosis SpA patients. The potential risk factors for thrombocytosis in SPA pati...
Recent studies of the vaginal microbiome have led to a better understanding of the microbiota and interactions with the host environment, however the role of the vaginal microbiome in vestibulodynia r...
This study aims to investigate and examine differences in the bacterial and fungal microbiome among patients with vestibulodynia and healthy controls....
A case-control study was conducted examining the vaginal microbiome of 29 patients with vestibulodynia and 26 controls through Stony Brook University Obstetrics and Gynecology ambulatory clinic. Exclu...
Principal component analysis (PCA) and linear discriminant analysis effect size (LefSe) were used to identify differences in relative abundance of operational taxonomic units (OTUs) for the vaginal mi...
Lactobacillus species were dominant amongst both cases and controls. PCA of 16S and ITS OTUs did not show significant differences in microbiome composition between vestibulodynia patients and controls...
Additional studies are needed to further assess the clinical significance of these findings....
Strengths of this study include ITS amplicon sequence analysis for fungal species diversity. Limitations of this study include small sample size and lack of racial diversity....
Our study did not find significant differences in composition or diversity between the vaginal microbiomes of cases of vestibulodynia and controls; however, the data suggests differences in abundance ...
Varied reports suggest a contentious relationship of bladder malignancy with pioglitazone in patients with type 2 diabetes....
To study an association (prevalence and predictors) of bladder malignancy with pioglitazone therapy in Asian-Indian type 2 diabetes patients....
In this observational multicenter study, type 2 diabetic patients attending out-patient diabetes-clinic were evaluated. A detailed history of anti-diabetic medication, dose, duration, pioglitazone usa...
A total of 8000 patients were screened out of which 1560 were excluded. Among 6440 included patients, 1056 (16.3%) patients were in group A and 5384 (83.6%) group B. Patients on pioglitazone were olde...
Pioglitazone use in Asian-Indians is not associated with an increased bladder cancer risk. However, pioglitazone should be restricted in individuals with history of hematuria. Age more than 58 years i...
Multiple chemical sensitivity (MCS) is a chronic condition characterized by the appearance of symptoms caused by exposure to chemical compounds that are tolerable for the general population. It mainly...
Stroke is the leading cause of mortality in China. DNA methylation has essential roles in multiple diseases, but its association with stroke was barely studied. We hereby explored the association betw...
The association was discovered in a hospital-based case-control study (cases/controls = 190:190) and further validated in a prospective nested case-control study including 139 cases who developed stro...
In our study, altered HTRA1 methylation was associated with stroke at clinical and preclinical stages and thus may provide a potential biomarker in the blood for the risk evaluation and preclinical de...
